CureDuchenne and Baebies: How a nonprofit and biotech startup are fighting ‘to save babies’

DURHAM – Back in 2003, new mother Debra Miller with her husband, Paul, founded CureDuchenne after their only son was diagnosed with Duchenne, a rapidly progressing form of muscular dystrophy.

No doubt, it’s been a long haul working to find the best therapies for the disease.

But there is now reason to be even more hopeful.

Talking strategic partnerships: Bill Wofford, Debra Miller, Richard West and Chris Pendland at LaunchBio’s Invest in Cures forum.

Just last month, the nonprofit headquartered in California announced a three-year partnership with Durham-based Baebies. A growth-stage company, Baebies is delivering innovative products and services for newborn screening and pediatric testing.

Read the full article here.

Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.

Donate